GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) » Definitions » Liabilities-to-Assets

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Liabilities-to-Assets : 0.66 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Total Liabilities for the quarter that ended in Dec. 2023 was ₽836.9 Mil. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Total Assets for the quarter that ended in Dec. 2023 was ₽1,277.8 Mil. Therefore, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 was 0.66.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Liabilities-to-Assets Historical Data

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Liabilities-to-Assets Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
Get a 7-Day Free Trial 0.65 0.68 0.70 0.84 0.66

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.84 0.55 0.58 0.66

Competitive Comparison of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets

For the Medical Care Facilities subindustry, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets falls into.



Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=836.931/1277.808
=0.65

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 is calculated as

Liabilities-to-Assets (Q: Dec. 2023 )=Total Liabilities/Total Assets
=836.931/1277.808
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC  (MIC:GEMA) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Business Description

Traded in Other Exchanges
N/A
Address
St. Gubkina, 3, Building 1, Floor 1, Pom. I, r. 24, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Headlines

No Headlines